CADTH | Evidence Driven
CADTH | Evidence Driven

Search CADTH

Filters

No filters applied.

Showing 61 - 70 results of 3646

Download as CSV

Revlimid for Newly Diagnosed MM – Details (Revlimid) (Last Updated: Dec 18, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Revlimid
Manufacturer:
Celgene Inc.
Submission Type:
Initial

Apremilast (Otezla) (Last Updated: Mar 31, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Otezla
Manufacturer:
Celgene
Submission Type:
Initial
Indications:

Arthritis, psoriatic

Ivermectin (Rosiver) (Last Updated: Mar 30, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Rosiver
Manufacturer:
Galderma Canada Inc.
Submission Type:
Initial
Indications:

Rosacea

Elosulfase alfa (Vimizim) (Last Updated: Aug 5, 2014)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Vimizim
Manufacturer:
BioMarin Pharmaceutical (Canada) Inc.
Submission Type:
Initial
Indications:

Mucopolysaccharidosis IVA (Morquio A syndrome)

Lomitapide (Juxtapid) (Last Updated: Jul 8, 2014)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Juxtapid
Manufacturer:
Aegerion Pharmaceuticals (Canada) Ltd.
Submission Type:
Initial
Indications:

Hypercholesterolemia, Homozygous Familial

Rifaximin (Zaxine) (Last Updated: Aug 5, 2014)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Zaxine
Manufacturer:
Salix Pharmaceuticals Inc.
Submission Type:
Initial
Indications:

Encephalopathy, Hepatic

Certolizumab pegol (Cimzia) (Last Updated: Jun 23, 2014)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Cimzia
Manufacturer:
UCB Canada Inc.
Submission Type:
Initial
Indications:

Ankylosing spondylitis

Infliximab (Inflectra) (Last Updated: Jun 17, 2014)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Inflectra
Manufacturer:
Hospira Healthcare Corporation
Submission Type:
Initial
Indications:

Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis

Canagliflozin (Invokana) (Last Updated: Jun 5, 2013)

Project Line:
Reimbursement Review
Project Status:
Withdrawn
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Invokana
Manufacturer:
Janssen Inc.
Submission Type:
Initial
Indications:

Diabetes mellitus, type 2

Somatropin (Genotropin) (Last Updated: May 27, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Genotropin
Manufacturer:
Pfizer Canada Inc.
Submission Type:
Initial
Indications:

Turner Syndrome